Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Zimmer Hip Replacement Lawyers: Network Zimmer Hip Replacement  Lawyer Win $2 Million Against Zimmer Hip Replacement Do You Have A Faulty Zimmer M/L Taper Hip Prothesis With Connective Technology and Cobalt Chromium Head? Do You Have Have Metallosis or Chromium Cobalt T...

Posts Tagged ‘Actos lawyer’

Florida Actos Lawyers

Written by lisaspitzer on . Posted in Actos Lawsuit Lawyers

Did you take actos for 1 year or longer? Were you diagnosed with bladder cancer?

You may have a lawsuit against the manufacturers of Actos.

Actos is a medication taken by Type II  ( adult onset ) diabetics to control their insulin production. Actos lawsuits are being filed for victims of bladder cancer from Actos.

Actos Lawsuit Overview

Actos lawsuits  allege  that long-term use of this  Type 2 diabetes drug caused patients to develop bladder cancer . These continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the proceeding’s next Case Management Conference will be held on Thursday, October 24, 2013, at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)

Actos Multi District Litigation

According to court documents Actos litigation involving bladder cancer lawsuits mounted up shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that use of the drug for 12 months or more had been associated with an increased risk of the disease. At that time, the FDA ordered Takeda Pharmaceuticals to add new warnings to the Actos label about its potential to cause bladder cancer.
Court filings indicate that more than 2,500 Actos lawsuits are now pending in the Western District of Louisiana, where the first case will go to trial in January. Plaintiffs in Actos lawsuits allege that Takeda Pharmaceuticals and other defendants concealed knowledge that the medication could increase a person’s chances of developing bladder cancer, and failed to provide adequate warnings about that risk to the public and medical community.
On the state level, two Actos claims involving bladder cancer allegations have already gone to trial. Last month, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, according to court records, the judge presiding over the trial tossed out the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)
This past April, a Los Angeles Superior Court jury awarded $6.5 million to a plaintiff who developed bladder cancer following four years of Actos use. However, the plaintiff is currently appealing a decision by the judge overseeing the case to grant Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Long-term users of Actos ( over 2 years ) who have been diagnosed with bladder cancer may be eligible to file an Actos lawsuit against Takeda Pharmaceuticals.

Can I File An Actos Lawsuit?

1. You must have taken Actos for over one year

2. You must have a confirmed diagnosis of bladder cancer

3. You must have no prior medical history of baldder cancer prior to taking Actos

Actos Lawsuit Update

Written by lisaspitzer on . Posted in Actos Lawsuit Lawyers, Drug Lawsuits, Florida Multidistrict Litigation Lawyers, Maine Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Minnesota Multidistrict Litigation Lawyers, Montana Multidistrict Litigation Lawyers, New Hampshire Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers, Rhode Island Multidistrict Litigation Lawyers, South Carolina Multidistrict Litigation Lawyers, Washington DC Multidistrict Litigation Lawyers, Washington Multidistrict Litigation Lawyers, Wisconsin Multidistrict Litigation Lawyers, Wyoming Multidistrict Litigation Lawyers

Actos is a medication taken by Type II  ( adult onset ) diabetics to control their insulin production. Actos lawsuits are being filed for victims of bladder cancer from Actos.

Actos Lawsuit Update

 Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the proceeding’s next Case Management Conference will be held on Thursday, October 24, 2013, at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)

Actos Lawsuit News

According to court documents Actos litigation involving bladder cancer allegations got underway shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that use of the drug for 12 months or more had been associated with an increased risk of the disease. At that time, the FDA ordered Takeda Pharmaceuticals to add new warnings to the Actos label about its potential to cause bladder cancer.
Court filings indicate that more than 2,500 Actos lawsuits are now pending in the Western District of Louisiana, where the first case will go to trial in January. Plaintiffs in Actos lawsuits allege that Takeda Pharmaceuticals and other defendants concealed knowledge that the medication could increase a person’s chances of developing bladder cancer, and failed to provide adequate warnings about that risk to the public and medical community.
On the state level, two Actos claims involving bladder cancer allegations have already gone to trial. Last month, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, according to court records, the judge presiding over the trial tossed out the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)
This past April, a Los Angeles Superior Court jury awarded $6.5 million to a plaintiff who developed bladder cancer following four years of Actos use. However, the plaintiff is currently appealing a decision by the judge overseeing the case to grant Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Long-term users of Actos ( over 2 years ) who have been diagnosed with bladder cancer may be eligible to file an Actos lawsuit against Takeda Pharmaceuticals.

Actos Lawsuit Criteria

1. You must have taken Actos for over two years

2. You must have a confirmed diagnosis of bladder cancer

3. You must have no prior medical history of baldder cancer prior to taking Actos

Drug and Devices Regulatory Boards, Class Action Lawyer Network Resources

Written by lisaspitzer on . Posted in Resources abd Regulatory agencies

The lawyers of Class Action Lawyer Network are filing dangerous drugs and devices lawsuits for: GranuFlo, Dialysis medications, Actos, Vaginal Mesh, Stryker Hip Replacement and others. Below is a handy resource of regulatory agencies:

Environmental Protection Agency

    pesticides (sets tolerance levels for residues on feed crops and raw and processed foods)
    municipal water supplies

FAX (703) 308-4776

Bureau of Alcohol, Tobacco, and Firearms

    alcoholic beverages and tobacco

FAX (202) 927-7862

Drug Enforcement Administration

    drugs of abuse

FAX (202) 307-9765

U.S. Department of Commerce

    exports

FAX (202) 482-5270

Health Care Financing Administration (HCFA)

    health care subsidies

FAX (410) 786-4633

Federal Trade Commission

    nonprescription drug and
    cosmetic advertising

FAX (202) 326-2050

National Marine Fisheries Services

    voluntary seafood inspection program

FAX (301) 713-2258

Occupational Safety and Health Administration

    workplace safety standards

FAX (202) 219-4761

U.S. Customs Service

    imports

FAX (410) 962-7470

Federal Bureau of Investigation

    Federal Anti-Tampering Act

FAX (202) 324-4705

Centers for Disease Control and Prevention

    Epidemiology of diseases and other health problems

FAX (404) 488-5973

Nuclear Regulatory Commission

    Licensing and regulation of the nuclear industry

FAX (301) 415-7020

 FDA Office of Surveillance and Epidemiology and the Division of Cardiovascular and Renal Products,

Telephone Numbers Frequently Asked of FDA
FDA General Inquiries

888-INFO-FDA

888-463-6332
  
FDA Centers & Offices 


Office of the Commissioner 888-INFO-FDA
Center for Biologics Evaluation and Research (CBER) 301-827-0372
Center for Devices and Radiological Health (CDRH) 301-796-7100
Center for Drug Evaluation and Research (CDER) 301-796-5400
Center for Food Safety and Applied Nutrition (CFSAN) 240-402-1600
Center for Veterinary Medicine (CVM)

888-FDA-VETS

888-332-8387

240- 276-9000
National Center for Toxicological Research (NCTR) 870-543-7130
Office of Regulatory Affairs (ORA) 301-827-3101
  
Safety 
FDA's emergency number 301-796-8240
866-300-4374
Food Safety Hotline 888-723-3366
FOIA requests 301-796-3900
MedWatch 800-332-1088
Vaccine Adverse Event Reporting System 800-822-7967
Registration of Food Facilities 800-216-7331
  
Ombudsman 
Office of the Chief Mediator and Ombudsman 301-827-3390
CDER Ombudsman 301-594-5443
CBER Ombudsman 301-827-0379
Animal and Veterinary Ombudsman 240-276-9015
CDRH Ombudsman 301-796-5699
  
Related Contacts 
Consumer Product Safety Commission 800-638-2772
Federal Trade Commission 877-382-4357
Treasury Department’s Alcohol and Tobacco Tax and Trade 877-382-4357
Dept. of Agriculture – Food Safety and Inspection Service 800-535-4555
EPA – Office of Pesticide Programs 202-260-2090

Regulatory Boards To Contact For Complaints

    Accountancy
    Alarm Systems Contractors Board
    Architectural & Engineering Examiners
    Auctioneer Commission
    Barber Examiners
    Collection Service
    Contractors/Home Improvement
    Cosmetology
    Employee Leasing (*now part of the Insurance Division)
    Funeral Directors, Embalmers and Burial Services
    Geology
    Home Inspector Licensing Advisory
    Land Surveyors
    Limited Licensed Electricians
    Limited Licensed Plumbers
    Locksmith Licensing Program Advisory
    Motor Vehicle Commission
    Private Investigation & Polygraph Commission
    Private Probation Service Council
    Private Protective Services
    Race Track Licensing Program
    Real Estate Appraisers
    Real Estate Commission
    Scrap Metals Registration Program
    Soil Scientist Licensing Program

Mirena IUD Lawyers Reviewing Cases For Perforated Uterus

Written by Class Action Lawyer on . Posted in Medical Device Lawsuits

The Mirena IUD is Manufactured by  Bayer Pharmaceuticals. Bayer has just been in the news for it's recent settlement of Yaz lawsuits for blood clots. Yaz has caused strokes, Pulmonary embolism, and heart attacks and deaths isn young women. Bayer seems to like birth control devices that harm young women and so we havew the Mirena IUD. The Mirena IUD is another device that is appearing to take it's toll on women. There are so many medical devices and Drugs that target women.

What is the Mirena silicone IUD ?

 The Mirena IUD is a long-acting, hormonal contraceptive. The IUD is inserted into the uterus to disrupt the egg and sperm. Merina also releases levonorgestrel, a progestin, which helps keep the woman’s ovaries from releasing eggs. Mirena is also called the Mirena Silicone IUD.

Mirena was approved by the FDA in 2000, and use has grown in recent years amid heavy promotion of Mirena as an easy form of birth control that lasts for 5 years or longer. Bayer has been attempting to promote Mirena IUD to appeal to younger and younger women and girls, despite serious risks that are becoming apparent. Mirena IUD lawyers have been reviewing thousands of files and adverse incident reports. Women are being harmed by the Mirena IUD

Lawyers  are accepting cases for the Mirena IUD where the Mirena has caused a perforation of the uterus

 

    Uterus Perforation: Mirena has reported incidents where there has been  puncture of  the uterus or embedment in the uterine wall. Mirena IUD perforation can cause internal scarring, infection or damage to other organs and may result in the need for surgery.
    Migration:  There have been reports where the Mirena IUD  migrated through the intraabdominal cavity, potentially resulting in intestinal peforations, intestinal obstruction, absecesses or adhesions.
    Expulsion: Partial or complete expulsion of Mirena IUD has been reported.This side effect may be more common among younger women using Mirena IUD, women who have not had children or women who have the device inserted immediately after childbirth or abortion.
    Infection: As a result of infection from Mirena IUD, women could suffer serious scarring that may deminish fertility or their ability to conceive, and in severe cases infection may be life-threatening and result in death from Mirena.

Mirena IUD Lawyers are reviewing cases where the IUD has ether migrated or severed an organ. These would necessitate surgery and immediate removal of the IUD. This is a medical emergency and women should seek immediate medical attention.

Bayer Received a Strict Warning form the FDA regarding it's advertising tactics

 In December 2009, the FDA issued a warning letter to Bayer over its promotions of Mirena. The FDA accused the drug manufacturer of overstating the efficacy of Mirena, presenting unsubstantiated claims, minimizing the risks of Mirena and using false and misleading presentations.

If you have complications from the Mirena IUD speak top your physician and conact our Mirena IUD legal Division to speak to a Mirena IUD lawyer.

Overview of Drugs and Medical Devices Harming Women, Lawyers Filing Lawsuits

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

          Discussion presented by our female medical Social Worker

Bladder Sling, Mirena IUD, Vaginal mesh, Yaz, Yasmin, Fosamax, Topomax, DePuy hip replacement recall, Actos, Breast Implants, Tylenol, avaira toric contact lenses and others are harming women.
          It is amazing to me how many dangerous drugs and medical devices are having an effect on women. The breast Implant Helpline hears from women thru-out the country regarding their horrific experiences with these mesh devices. Yet, there are so many other drugs and medical devices that are hurting women. The Mirena birth control device, Yaz, Yasmin, Ocella, The DePuy Hip Replacement, metal on metal hip replacements, Zimmer Duram Cup, Breast Implants, Cytotec, Topamax and others,
Mirena Birth Control device

Mirena Silicone IUD
          The Mirena Birth control device has caused amongst other side effects: Miscarriage, Risk Of Infertility, Intrauterine Pregnancy, Streptococcal Sepsis, Pelvic Inflammatory Disease Cervix, Severe Pain, Contraceptive Perforation and other side effects.
Some women have experienced serious adverse side-effects and potentially life-threatening complications following the implantation of the Mirena device, including perforation of or imbedment in the uterus.
Bayer actually marketed Mirena as a way women could simplify their lifestyle. One of the ways it did so was through "Mirena Parties." Working with the social networking site Mom Central, Bayer created a Mirena direct marketing program that consisted of a series of house parties hosted by members of the Mom Central community. Bayer was eventually warned against this. The stories have heard and read regarding this device are horrific.
WARNINGS AND PRECAUTIONS
Ectopic Pregnancy
          Evaluate women who become pregnant while using Mirena for ectopic pregnancy. Up to half of pregnancies that occur with Mirena in place are ectopic. The incidence of ectopic pregnancy in clinical trials that excluded women with risk factors for ectopic pregnancy was approximately 0.1% per year.
"Tell women who choose Mirena about the risks of ectopic pregnancy, including the loss of fertility."
     Other Adverse Effects from the use of Mirena:
     Sepsis, ovarian cyst formation, breast cancer, damage to conceived children, PID, embedment, amenorrhea, perforation of uterine wall or cervix may occur during insertion

Cytotec (Misoprostol)
        It is estimated that in about 200,000 births in one year, Cytotec was used to stimulate delivery. This is where most of the problems with this drug, including birth defects have incurred. The purpose of the drug was for the prevention of ulcers, but it has also been used in abortions. Brain damage to infants is of particular concern.\

Yaz, yasmin Birth Control Pills
         Studies recently published in the British Medical Journal, which concluded that women ages 15-44 taking birth control pills containing the synthetic progestin, drospirenone, are more likely to develop blood clots deep in the veins of the leg (venous thromboembolism), than women using birth control pills containing the common progestin levonorgestrel. The studies reported that the risk of developing blood clots for women taking the drospirenone-containing pills may be two to three times greater than those who take other pills. Yaz is one of these drugs.

Potential Yasmin and Yaz side effects may cause:

  •  Heart Attacks
  • Strokes
  • Cardiac Arrhythmias
  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Liver damage
  • Anaphylactic Shock
  • Pulmonary Embolism (PE)
  • cervical cancer
  • severe migraines
  • Hair loss
  • Gallbladder Disease
  •  Death

List of Drugs similiar to Yaz and Yasmine
         Approved Oral Contraceptives containing Drospirenone
Drospirenone and ethinyl estradiol Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Ocella Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Safyral Drospirenone 3 mg, ethinyl estradiol 0.03 mg, and levomefolate calcium 0.451 mg
Syeda Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Yasmin Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Zarah Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Beyaz Drospirenone 3 mg, ethinyl estradiol 0.02 mg and levomefolate calcium 0.451 mg
Drospirenone and ethinyl estradiol Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Gianvi Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Loryna Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Yaz Drospirenone 3 mg and ethinyl estradiol 0.02 mg

Topamax
          Topiramate, the generic form of Johnson & Johnson's anti-seizure drug, Topamax, is under fire from the Food & Drug Administration for its birth defect risks, Reuters reports. The medication is prescribed to patients suffering from epilepsy, and more popularly, to consumers with chronic migraine headaches. Topiramate has recently been combined with other drugs to battle obesity and bipolar disorder. More than 4.7 million prescriptions for Topamax were filled in the United States from 2007 to 2010, bringing in approximately $600 million worldwide last year.
In March 2011, the FDA issued a warning that Topamax side effects may increase the risk of oral cleft birth defects, such as cleft lip and cleft palate, among babies born to mothers who took the drug during the first trimester of pregnancy. As a result of inadequate warnings previously provided, many women were not aware they may be exposing their baby to a potential risk of Topamax birth defect.
If one looks att all the current medical devices and drugs with complications the effects on women are staggering:? A new report says women are most likely to be injured.

FOSAMAX EFFECTS WOMEN
         The .Long-Term use of Fosamax has been shown to more then double the Risk of Femur Fractures Among Older Women.
An article in an issue of the Journal of the American Medical Association reports that long-term use of Fosamax and other bisphosphonate drugs by older women more than doubles their chance of suffering femur fractures. This side effect is particularly disturbing in light of the fact that Fosamax and similar drugs are prescribed to strengthen the bones of women with osteoporosis.
          The article summarizes a study of Canadian women aged 68 years and older who had taken oral bisphosphonates like Fosamax for five years or more. The study found that women who had taken Fosamax and related drugs for five years or longer were 2.74 times more likely to suffer a femur fracture than women who had taken the drug for only 100 days or less. In fact, the study concluded that more than half of the femur fractures among women who had taken bisphosphonates for five years or more were attributable to their use of bisphosphonates.
         A number of Fosamax lawsuits seeking financial compensation have already been filed against Merck & Co. for injuries caused as a result of serious

TRANSVAGINAL MESH AND RELATED MESH PRODUCTS
 Manufacturers of Mesh Products Include:

  • Johnson & Johnson
  • Ethicon TVT
  • Gynecare TVT
  • Gynemesh PS
  • Prolene Polypropylene Mesh Patch
  • Secur
  • Bard
  • Avaulta Plus BioSynthetic Support System
  • Avaulta Solo Synthetic Support System
  • Faslata Allograft
  • Pelvicol Tissue
  • PelviSoft Biomesh
  • Pelvitex Polypropylene Mesh
  • American Medical Systems or AMS
  • SPARC
  • Boston Scientific
  • Advantage Sling System
  • Obtryx Curved Single
  • Obtryx Mesh Sling
  • Prefyx Mid U Mesh Sling System
  • Prefyx PPS System

           Vaginal mesh implants have been used to correct uterine prolapse and incontinence but the complications are effecting women thru-out the United States, Canada and the U.K.
complications include:

  • Erosion of vaginal tissue can result from a vaginal mesh
  • Hardening of the vaginal mesh
  • Infection is a serious vaginal mesh-patch complication
  • Severe Pain and discomfort
  • Perforations of the bowel, bladder or blood vessels
  • Recurrence of Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI)
  • Urinary problems and more severe incontinence
  • painful sexual intercourse
  • Vaginal mesh erosion
  • Vaginal scarring

           The transvaginal mesh Continues to effect women and alter the lives of Women and
Recent warnings have linked various birth control drugs and devices to serious injuries and even death.

Metal On Metal Hip Replacements like the DePuy and Zimmer
          Women are reporting more problems, and a higher failure rate, with the DePuy ASR XL Acetabular hip replacement system than men. It turns out they're also more prone to some of the serious side effects of the poorly-designed implant, including metallosis.
Statistics show individuals with a small stature, such as women may be more susceptible to failure of DePuy ASR hip implants.

.
Dow Corning Breast Implants
Breast Implant Lymphoma
          In January 2011, The U.S. Food & Drug Administration (FDA) advised that women who had received breast implants should notify their doctors of any changes in their breasts because of a possible association with a rare type of lymphoma. In breast implant patients, ALCL has occurred in the scar capsule adjacent to the implant.
Symptoms of breast implant lymphoma include:

  • Pain
  • Lumps
  • Swelling

        Asymmetry that developed after their initial surgical sites were fully healed
Historically, women are more often exposed to dangerous medical products and medical negligence than men. Some medical malpractice claims, for instance, are unique to women—like obstetrical malpractice and sexual assault by health care providers. In addition, women suffer harm from gender-specific products such as breast implants, birth control pills, osteoporosis medications and birth control devices like IUDs.
In the age of prescription drugs and antidepressants, where drugs are administered over-the-counter without any major restrictions, more people are dying each year from medications than from traffic accidents. A recent L.A. Times article looked at the impact prescription drugs have upon American society, and their dangers if used in certain combinations.
In 2009, prescription drugs factored in the deaths of over 37,000 people. Less people died in motor vehicle accidents that year, which was a new phenomenon, according to the U.S. Centers for Disease Control and Prevention.
           It is hoped that the new bill coming before congress will protect women from manufacturers whose products slip thru and eventually are either recalled or end up with warnings. These drugs and medical devices are hurting women.

Actos Lawyers Filing Actos Lawsuits, Actos Linked to Bladder Cancer

Written by Class Action Lawyer on . Posted in Actos Lawsuit Lawyers, Drug Lawsuits, Multidistrict Lawsuit News

Actos Linked To Bladder Cancer

 Actos has been linked to bladder cancer with use of over 2 years.

Seniors and minority groups are usual victims of Actos. Actos is a drug used for Type II, adult onset, diabetis.

Thousands of Actos Bladder Cancer  Lawsuits Are  Anticipated

Actos Timeline Gives The Actos Lawsuit Statute  Starting Date

Jun 10, 2011: Use of Actos is banned in France and Germany. The French Medicines Agency removed the drug from the market after analyzing the data collected from 2006 to 2009.

Jun. 15, 2011: FDA announces “that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” Warning labels are to be updated subsequently. The agency warns healthcare professionals against prescribing Actos in patients who have bladder cancer or have a history of bladder cancer.

Jul. 2011: The EMA states that Actos should include the risk of bladder cancer on its warning label, according to Reuters.

Aug.  4, 2011: – The FDA approves the label change for product containing pioglitazone (marketed as Actos, Actoplus Met, and Duetact) previously announced on June 15, 2011.

Actos Lawsuit  MDL Consolidation

Actos pillsThousands of Actos lawsuits are anticipated in the multidistrict litigation (MDL) filing ordered by Judge Rebecca Doherty. The honorable Judge Doherty stated in a recent order that "the number of claims which will be included could reach into the thousands," in reference to the new Actos lawsuit MDL she ordered be created. Judge Doherty is not presiding over an Actos class action lawsuit.
The MDL was created so that Judge Doherty will have one common point of reference for the thousands of cases expected. This specific MDL lets all of the affected Actos users work together so they are all essentially covered under one lawsuit (similar to a class action.) Unlike an Actos class action lawsuit, where the payout per participant may be small, an award from the Actos MDL could amount to tens or hundreds of thousands of dollars per litigant. It could even be in the million dollar range if the an Actos user's death was tied back to taking Actos and developing bladder cancer or another severe adverse side effect of Actos.

Get An Actos Lawyer

An experienced Actos attorney will be able to help determine what financial awards may be possible based on the severity of the injury and required treatment due to taking Actos.

Actos Bladder Cancer Symptoms

It's important that Actos users know what to look out for if they have taken Actos for more than one year which allegedly increases the risk of bladder cancer by at least 40%. Symptoms of bladder cancer include tumors which could cause blood in the urine, painful or frequent urination, or straining during urination. In addition, other common symptoms of bladder cancer include fatigue, incontinence, weight loss and bone pain or tenderness. If you are experiencing these symptoms you should see a doctor immediately so bladder cancer or tumors can be ruled out.

Speak To An Actos Bladder Cancer Lawyer and See Your Doctor Right Away

If you are experiencing these symptoms and are diagnosed with bladder cancer or tumors it may be a good idea to speak with an attorney to see if you are able to file an Actos lawsuit under the new MDL.

 

Actos Lawyers, Actos News, Actos Bladder Cancer Victims

Written by Class Action Lawyer on . Posted in Louisiana Multidistrict Litigation Lawyers

Actos has warnings for bladder cancer. Actos cases have been consolidated and Actos Lawyers are accepting clients.

The judge overseeing lawsuits alleging Takeda Pharmaceutical Co. (4502)’s Actos diabetes medicine causes cancer appointed 19 plaintiffs’ lawyers to manage litigation involving U.S. claims.

Takeda, Asia’s biggest drugmaker, may face as many as 10,000 claims that Actos causes bladder cancer after U.S. regulators found last year the drug was linked to the disease. Federal lawsuits against the drugmaker were consolidated before U.S. District Judge Rebecca Doherty in Lafayette, Louisiana, in December. The first hearing on the cases is set for March 22, according to court filings.

“The court has determined to effect the selection of lead counsel, liaison counsel and plaintiffs’ executive and steering committees before the March 22nd-23rd status conference,” Doherty said in a March 12 note posted on the court’s website.

The lawsuits claim patients who use Actos, a prescription drug approved to treat type 2 diabetes, face increased risks of developing bladder cancer. The plaintiffs also claim that Takeda and co-defendant Eli Lilly & Co., based in Indianapolis, withheld information about the risk and failed to provide adequate warnings.

Takeda pulled Actos, its top-selling drug, off the market in Germany and France last year after it was linked to an increased cancer risk. The medication had sales of 387.9 billion yen ($4.8 billion) last fiscal year, 27 percent of the Osaka, Japan-based company’s revenue.
Lead Counsel

“Given that litigation is pending, we can’t comment,” Jocelyn Gerst, a U.S.-based spokeswoman for Takeda, said in a telephone interview about the selection of the plaintiffs’ group.

Doherty named attorneys Richard Arsenault and Paul Pennock as lead plaintiffs’ counsel in the case and also appointed them to the executive committee, along with lawyers Mark Robinson and Hunter Shkolnik.

Arsenault, a products-liability lawyer based in Alexandria, Louisiana, served as one of the lead lawyers in consolidated cases filed against Merck & Co. (MRK) over its Vioxx painkiller that resulted in a $4.85 billion settlement in November 2007.

Pennock, a New York-based attorney, was one of the lawyers leading the consolidated suits against AstraZeneca Plc (AZN) over its Seroquel antipsychotic drug. The London-based drugmaker agreed last year to pay a total of about $350 million to resolve patients’ claims that the drug caused diabetes.
Steering Committee

The Los Angeles-based Robinson, who has won multimillion- dollar jury awards against carmakers such as Ford Motor Co., is a co-lead counsel in sudden-acceleration lawsuits against Toyota Motor Corp. (7203)

Shkolnik, based in New York City, served as a member of the plaintiffs’ steering committee in lawsuits against Medtronic Inc. (MDT) over flawed heart defibrillators. The cases later settled for more than $114 million.

Other lawyers named to the plaintiffs’ steering committee in the Actos cases include Mark Lanier, a Texas-based lawyer who won the first jury award against Whitehouse Station, New Jersey- based Merck in the Vioxx litigation, and Chris Seeger, a New Jersey-based attorney who also won a verdict against Merck on behalf of Vioxx users.

The judge also named Andy Birchfield, an Alabama-based lawyer who helped negotiate the $4.85 billion Vioxx settlement, and Vance Andrus, a Lafayette-based lawyer who was one of the lead counsels in cases against GlaxoSmithKline Plc (GS) over its Avandia diabetes drug. The London-based drugmaker has agreed to pay more than $700 million to resolve claims that Avandia caused heart attacks and strokes in users.

The lawsuits are consolidated in In Re: Actos Products Liability Litigation, 11-2299, U.S. District Court, Western District of Louisiana (Lafayette).

Lawyers Still Accepting Actos Cases, Actos Causing Bladder Cancer

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Lawyers Still Accepting Actos Cases as First Hearing Set to Begin. If you or a loved one has been diagnosed with bladder cancer from Actos contact us for an Actos lawyer today.

10,000 Actos lawsuits are expected to be filed
Orlando, FL (PRWEB) February 21, 2012
A federal judge tasked with overseeing the litigation over whether a popular diabetes drug caused bladder cancer in hundreds of patients is moving quickly to expedite the legal process for both sides.
While those who have already filed an Actos lawsuit are one step closer to having their day in court, lawyers are still helping those who are just coming forward with side effects.
On Monday, February 13, U.S. District Judge Rebecca Doherty issued an order scheduling a pretrial status conference in the Actos litigation for March 22, 2012. The hearing will give representatives of the drug manufacturer and those of patients alleging bladder cancer from the drug a chance to discuss trial preparation and whether any progress has been made in reaching a settlement.
After the hearing, Judge Doherty will also appoint lead counsel in the consolidated cases from her bench in Lafayette, Louisiana.
Doherty was originally assigned to dozens of the lawsuits in Multi-District Litigation following an order by the U.S. Judicial Panel on Multidistrict Litigation in December. She now presides over approximately 150 cases and lawyers expect thousands more may be filed before litigation is complete. The pending case is In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).
Lawyers with the Actos Resource Center have responded to hundreds of inquiries from those who have taken Actos and expect many more will come forward due to the popularity of the drug.
On June 15, 2011, the FDA issued a warning that taking Actos for longer than one year could heighten the risk of bladder cancer. Approved by the FDA in 1999, Actos had become one of the most popular diabetes drugs in the world after rival Avandia was linked to heart problems.
The warning came after a study of 155,000 patients over four years by the French Medicines Agency showed taking Actos could increase the occurrence of bladder cancer by up to 40%.
Authorities in France and Germany quickly banned sales of the drug. However, it remains on the market in the United States.
Now, according to a Bloomberg article published December 1, 2011, drug makers Takeda Pharmaceuticals and Eli Lilly could face as many as 10,000 lawsuits from those stricken with bladder cancer after taking Actos.
On Tuesday, Takeda released a statement saying "Takeda is confident in the therapeutic benefits of Actos and its importance as a treatment for type 2 diabetes. As a science and evidence-based company, Takeda firmly stands behind the substantial data available confirming the positive risk/benefit profile of Actos, which includes twelve years of clinical and patient experience with the product."
For more information on the side effects, FDA warnings and litigation associated with Actos, visit ActosCancer.com.

Class Action Lawyer Netrwork Actos Lawyers are accepting cases for bladder cancer form Actos. These are part of an Actos Multi District litigation.

Actos for causing Bladder Cancer, First Hearing being held

Written by Class Action Lawyer on . Posted in Drug Lawsuits

Actos has been shown to cause bladder cancer. First hearing being held for Actos and Class Action Lawyer Nework Actos Lawyers are accepting new cases.

 

(AP)  NEW ORLEANS — A federal judge in Louisiana has scheduled an initial court hearing for a batch of lawsuits that claim Takeda Pharmaceuticals' top-selling diabetes drug, Actos, carries an increased risk of bladder cancer.

In an order issued Monday, U.S. District Judge Rebecca Doherty said she plans to appoint lead attorneys for the consolidated cases after the March 22 status conference in her Lafayette, La., courtroom.

In December, the U.S. Judicial Panel on Multidistrict Litigation assigned Doherty to preside over dozens of lawsuits against Actos maker Takeda Pharmaceuticals America Inc., which is based in Deerfield, Ill. Plaintiffs' attorneys expect to file several thousand claims against Takeda and its related companies on behalf of people who used the drug.

Takeda's Japanese parent company, Takeda Pharmaceuticals Co. Ltd., halted sales of Actos in Germany and France last year. The U.S. Food and Drug Administration issued a warning about the drug's possible cancer risks in 2010 but allowed sales to continue.

After the FDA approved Actos in 1999, Takeda co-promoted the drug in the U.S. with Eli Lilly & Co. Takeda took over responsibility for the drug's marketing when the agreement between the company ended in 2006, attorneys for the companies said in court papers.

An FDA spokeswoman says information about a possible risk of bladder cancer associated with the use of Actos has been on its label since the drug was approved for treating Type 2 diabetes in 1999.

Takeda released a statement on Tuesday saying that it works hard to evaluate any potential risks associated with its products.

"Takeda is confident in the therapeutic benefits of Actos and its importance as a treatment for type 2 diabetes. As a science and evidence-based company, Takeda firmly stands behind the substantial data available confirming the positive risk/benefit profile of Actos, which includes twelve years of clinical and patient experience with the product," the statement said.

The first lawsuit linking Actos to bladder cancer was filed against Takeda and Eli Lillly in July 2011, according to the companies' lawyers.

Paul Pennock of Weitz & Luxenberg, a New York firm that represents dozens of people with Actos-related claims, said Judge Doherty is now handling roughly 150 of these suits. Thousands more could have federal claims filed in or transferred to Lafayette by the end of the year, he said.

"People should not run the risk of getting bladder cancer from treating their diabetes given the many other excellent therapies available," Pennock said.

Thousands of other claims involving Actos are expected to be heard in California and Illinois state courts.

The lawsuits claim researchers have found that people who take Actos for more than a year are at increased risk of developing bladder cancer. The suits also accuse Takeda of concealing their knowledge of the cancer risks and failing to adequately warn consumer and health care providers.

Actos sales in the U.S. fell by roughly 3 percent last year, but the drug remained the best-selling Type 2 diabetes drug on the market, according to the health care information firm IMS Health. The firm says Actos accounted for $3.4 billion in sales in 2011, or nearly 84 percent of sales among drugs in the same class.

Class action layers of Class Action lawyer Network are accepting cases of bladder cancer form Actos. Multi District litgation filed

New News on Actos, Takeda Named In Actos Lawsuits

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Takeda named in suits over use of diabetes drug Actos
2/2/2012 7:32 AM By Andrea Dreaden

 

Three Illinois couples have filed lawsuits claiming the manufacturers of a diabetes medication knew the drug caused cancer but intentionally hid that from patients.

Donald E. and Sharon Sandidge, of Alton, Phillip A. and Mickey Block, of Rinard, and John L. and Sandra Allen, of Washington, each filed complaints Jan. 18 in Madison County Circuit Court against Takeda Pharmaceuticals America Inc., Takeda Pharmaceuticals North America Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company.

Donald Sandidge, Phillip Block and John Allen say they were each prescribed Actos for the long-term maintenance of high blood sugar. Produced joinly by Deerfield, Ill.-based Takeda and Eli Lilly, Actos was first manufactured to be used by patients in 1999. The diabetes drug received FDA approval later that year.

The three men say they took Actos every day as part of their doctors' plans to treat type-2 diabetes. They say it wasn't until they had been taking the drug for several years that they learned the blood-sugar-lowering medication increased the likelihood of developing bladder cancer.

Sandidge, Block and Allen have all been diagnosed with bladder cancer since taking Actos, according to the complaint.

The complaints cite numerous studies documenting an increased risk of bladder cancer in patients taking Actos for more than 12 months. The men, however, claim none of those studies have ever been released or published by researchers or the defendants. They contend Takeda and Eli Lilly intentionally withheld that information to avoid Actos being rejected by the FDA.

An FDA study in late 2010 allegedly found an increased risk of bladder cancer in patients using Actos. The patients say the manufacturers publicly denied the accuracy of the findings and continued to tout Actos as safe for patients.

Based on the results of that 2010 study, the FDA issued a safety announcement in June 2011 that said the "use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer." The information was immediately added to the drug's warning label.

A month after the FDA warning, Sandidge, Block and Allen claim Takeda Limited issued a recall on Actos in France but refused to issue the same recall in the U.S. They say the companies allowed profits to overshadow patient safety. The men claim the diabetes medication accounts for $4.8 billion — approximately 27 percent — of the company's revenue.

Sandidge, Block and Allen accuse the defendants of knowingly "concealing their knowledge of Actos' unreasonably dangerous risks" from patients, their doctors, other consumers and the medical community as a whole. They say they each have bladder cancer as a direct result of the companies' failure to properly share information with patients. Had those risks been disclosed, the men say they would not have taken Actos.

The three men and their wives accuse Takeda and Eli Lilly of negligence, strict liability and negligent failure to warn for allegedly hiding information about the risks posed by Actos. They say the companies were also negligent for failing to improve the medication and reduce the risk posed to patients. They say the manufacturers knew that the risks of Actos far outweighed its benefits yet continued to distribute the drug. They also accuse the defendants of breach of express warranty and violation of Illinois Consumer Protection laws.

The Sandidges, Blocks and Allens say they have endured pain and suffering, economic loss and loss of consortium as a result of the defendants' alleged negligence. The couples are each asking to be awarded more than $50,000 in actual damages along with punitive damages and court costs.

Attorneys Trent B. Miracle and John J. Foley of the Simmons firm in Alton and Paul Hanly and Jayne Conroy of New York are representing the three couples. They demand a jury trial.

If you or a loved one has been injured by Actos causing bladder cancer contact Class Action Lawyer Network today.